Ibhanti kunye nendlela: Intsebenziswano, uVumelwano kunye nokuphumelela phakathi koBuntu
iimveliso

Iimveliso

I-Adefovir CAS:106941-25-7

I-Adefovir, enefomyula yekhemikhali i-C8H12N5O4P, sisithinteli se-nucleotide analog reverse transcriptase esisetyenziswa kunyango lwe-hepatitis B engapheliyo. Ikwaphandwa malunga nokusetyenziswa kwayo kwiintsholongwane ekulawuleni ezinye izifo zentsholongwane.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Ukusetyenziswa kunye nesiphumo:

I-Adefovir idlala indima ebalulekileyo ekulawuleni i-hepatitis B engapheliyo, isebenza njengeyeza elibalulekileyo lokulwa neentsholongwane. Isetyenziselwa ukuthintela ukuphindaphinda kwentsholongwane ye-hepatitis B (HBV) ngokuphazamisa i-DNA polymerase yentsholongwane, ekugqibeleni icinezele ukwenziwa kwe-HBV DNA. Le ntshukumo inegalelo ekunciphiseni umthwalo wentsholongwane kwizigulane ezine-hepatitis B engapheliyo, ngaloo ndlela inceda ekunciphiseni umonakalo wesibindi kunye nokuthintela ukuqhubeka kwesifo. Iimpawu ze-Adefovir zokulwa neentsholongwane zenza ukuba ibe yinxalenye ebalulekileyo yesixhobo sonyango lwe-hepatitis B engapheliyo, ibonelela ngokhetho oluxabisekileyo lonyango kwizigulane ezichaphazelekileyo yile meko. Ngaphezu koko, i-Adefovir iphandwe ngezicelo zayo ezinokubakho ekulawuleni ezinye izifo zentsholongwane, kubandakanya i-human immunodeficiency virus (HIV) kunye ne-herpesviruses. Indlela esebenza ngayo njenge-nucleotide analog reverse transcriptase inhibitor ivumela ukuba iqwalaselwe ukusetyenziswa kunyango oludibeneyo losulelo lwe-HIV. Ukongeza, umsebenzi wayo wokulwa neentsholongwane kwiintsholongwane ezithile ze-herpes ubonisa ukuba iluncedo ekulawuleni usulelo lwe-herpesvirus, inegalelo ekuphononongweni kweendlela ezintsha zonyango lwezi zifo zentsholongwane. Uphuhliso kunye novavanyo lwe-Adefovir lubonisa ukubaluleka kwayo kunyango lwe-antiviral kunye nolawulo lwezifo ezisulelayo. Indima yayo ekusombululeni i-hepatitis B engapheliyo kunye nobuchule bayo bophando ekulawuleni ezinye izifo ezibangelwa yintsholongwane igxininisa ukubaluleka kwayo kwi-virology, i-pharmacology, kunye neyeza zonyango. Uphando oluqhubekayo kunye novavanyo lweklinikhi lwe-Adefovir lugxininisa imizamo eqhubekayo yokwandisa ukusetyenziswa kwayo kwezonyango kunye nokuphucula igalelo layo kwizicwangciso zokulwa neentsholongwane. Ngamafutshane, ukusetyenziswa kwe-Adefovir kubandakanya indima yayo ebalulekileyo kunyango lwe-hepatitis B engapheliyo kunye nokusetyenziswa kwayo okunokwenzeka ekulawuleni ezinye izifo ezibangelwa yintsholongwane, okubonisa ukubaluleka kwayo kunyango lwe-antiviral kunye nophando lwezifo ezisulelayo. Iimpawu zayo ze-pharmacological kunye neendlela zayo zokulwa neentsholongwane ziyibeka njengeyeza elixabisekileyo kwicandelo le-virology, inikezela ngeendlela ezithembisayo zophuhliso lonyango olusebenzayo kwiintlobo ngeentlobo zezifo ezibangelwa yintsholongwane ezichaphazela impilo yehlabathi.

Isampulu yeMveliso:

I-L-Arginine1
I-L-Arginine2

Ukupakisha imveliso:

I-L-Arginin3

Iinkcukacha ezongezelelweyo:

Ukwakhiwa C8H12N5O4P
Uvavanyo 99%
Inkangeleko umgubo omhlophe
Inombolo ye-CAS 106941-25-7
Ukupakisha Encinci kwaye ininzi
Beka ubomi kwishelufa iminyaka eyi-2
Indawo yokugcina izinto Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso I-ISO.

 


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha uze uwuthumele kuthi